Pharmafile Logo
Pharmafocus logo
Advanced Search

Axovant

Showing 4 posts of 4 posts found.

handshake2

Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal

June 7, 2018
Sales and Marketing Axovant, Oxford BioMedica, biotech, drugs, pharma, pharmaceutical

Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, …

News
shutterstock_273326141

Axovant snatches Teva and Allergan execs to strengthen management

June 5, 2018
Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …

News
biology-think-networking-physiology-brain-anatomy-2676370

Axovant’s drug bested by placebo, shares reduced to dust

January 8, 2018
Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical

The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …

News
brainss

Axovant shares capitulate after Alzheimer’s drug failure

September 26, 2017
Research and Development Alzheimer's, Axovant, biotech, drugs, pharma, pharmaceutical

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026